Focus Financial Network Inc. Sells 1,725 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Focus Financial Network Inc. reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 44,709 shares of the healthcare conglomerate’s stock after selling 1,725 shares during the period. UnitedHealth Group accounts for approximately 0.9% of Focus Financial Network Inc.’s portfolio, making the stock its 21st largest position. Focus Financial Network Inc.’s holdings in UnitedHealth Group were worth $22,616,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Kathleen S. Wright Associates Inc. purchased a new stake in UnitedHealth Group in the third quarter worth about $27,000. AlphaMark Advisors LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $30,000. RPg Family Wealth Advisory LLC purchased a new position in UnitedHealth Group during the third quarter valued at $37,000. Friedenthal Financial bought a new position in shares of UnitedHealth Group in the 3rd quarter worth about $51,000. Finally, Highline Wealth Partners LLC purchased a new stake in UnitedHealth Group in the third quarter worth about $55,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 1.2 %

NYSE UNH opened at $533.17 on Tuesday. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a market capitalization of $490.66 billion, a P/E ratio of 34.40, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61. The stock’s 50-day moving average price is $529.18 and its 200-day moving average price is $564.40. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the company earned $5.83 EPS. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link. 0.33% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of research firms recently weighed in on UNH. UBS Group reduced their price objective on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. TD Cowen increased their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Barclays cut their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a report on Friday, January 17th. Truist Financial reduced their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Finally, Wells Fargo & Company reduced their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.